Skip to content

NANOVIRICIDES, INC.: 10-Q filed 2014-02-14

What NANOVIRICIDES, INC. reported in its quarterly report filed 2014-02-14 (fiscal Q2 2014): 24 published measures, 98 facts as tagged in accession 0001144204-14-009813.

This filing

Form
10-Q (quarterly report)
Filed
2014-02-14
Fiscal period
fiscal Q2 2014
Accession
0001144204-14-009813 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NANOVIRICIDES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3122,888,676USD
At 2013-06-3016,407,554USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3112,678,008USD
At 2013-06-308,397,902USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-3110,210,668USD
At 2013-09-3011,751,247USD
At 2013-06-308,009,652USD
At 2012-06-3013,850,193USD
At 2011-06-3010,170,891USD
At 2010-06-306,518,677USD
At 2009-06-302,485,541USD
At 2008-06-30443,739USD
At 2007-06-30500,338USD
At 2006-06-301,238,456USD
At 2005-06-30-66,005USD
At 2005-05-110USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-3116,948,832USD
At 2013-06-3013,923,245USD
At 2012-12-3113,879,902USD
At 2012-06-3014,274,985USD
At 2005-05-110USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-1,692,382USD92
2013-07-01 to 2013-12-31-7,965,162USD184
2005-05-12 to 2013-12-31-46,264,946USD3156
2013-07-01 to 2013-09-30-6,272,780USD92
2012-07-01 to 2013-06-30-8,875,668USD365
2012-10-01 to 2012-12-31-1,208,385USD92
2012-07-01 to 2012-12-31-3,012,340USD184
2011-07-01 to 2012-06-30-6,207,207USD366
2010-07-01 to 2011-06-30-6,477,166USD365
2009-07-01 to 2010-06-30-4,744,208USD365
2008-07-01 to 2009-06-30-2,787,798USD365
2007-07-01 to 2008-06-30-2,738,337USD366
2006-07-01 to 2007-06-30-3,118,963USD365
2005-07-01 to 2006-06-30-3,284,432USD365
2005-05-12 to 2005-06-30-66,005USD50

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-07-01 to 2013-12-312,357,983USD184
2005-05-12 to 2013-12-313,863,631USD3156
2012-07-01 to 2012-12-310USD184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-10-01 to 2013-12-310USD92
2013-07-01 to 2013-12-310USD184
2005-05-12 to 2013-12-310USD3156
2012-10-01 to 2012-12-310USD92
2012-07-01 to 2012-12-310USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-312,720,807USD
At 2013-06-30468,896USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-1,751,412USD92
2013-07-01 to 2013-12-31-3,640,194USD184
2005-05-12 to 2013-12-31-39,038,260USD3156
2012-10-01 to 2012-12-31-1,243,604USD92
2012-07-01 to 2012-12-31-2,837,244USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3117,755,223USD
At 2013-06-3014,521,625USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-10-01 to 2013-12-31125,514USD92
2013-07-01 to 2013-12-31246,500USD184
2005-05-12 to 2013-12-31423,538USD3156

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-311,355,762USD
At 2013-06-301,178,184USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-10-01 to 2013-12-311,751,412USD92
2013-07-01 to 2013-12-313,640,194USD184
2005-05-12 to 2013-12-3139,038,260USD3156
2012-10-01 to 2012-12-311,243,604USD92
2012-07-01 to 2012-12-312,837,244USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-10-01 to 2013-12-311,130,478USD92
2013-07-01 to 2013-12-312,304,699USD184
2005-05-12 to 2013-12-3125,108,759USD3156
2012-10-01 to 2012-12-31710,197USD92
2012-07-01 to 2012-12-311,920,015USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3150,042,132shares
At 2013-06-3047,026,173shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-3156,422,575USD
At 2013-06-3046,259,420USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-313,859,244USD
At 2013-06-301,505,648USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-311,138,437USD
At 2013-06-301,036,752USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-12-31412,646USD
At 2013-06-30417,033USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-31224,890USD
At 2013-06-30204,359USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-1,692,382USD92
2013-07-01 to 2013-12-31-7,965,162USD184
2005-05-12 to 2013-12-31-46,264,946USD3156
2012-10-01 to 2012-12-31-1,208,385USD92
2012-07-01 to 2012-12-31-3,012,340USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31620,934USD92
2013-07-01 to 2013-12-311,335,495USD184
2005-05-12 to 2013-12-3114,350,343USD3156
2012-10-01 to 2012-12-31533,407USD92
2012-07-01 to 2012-12-31917,229USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-07-01 to 2013-12-31106,072USD184
2005-05-12 to 2013-12-311,142,824USD3156
2012-07-01 to 2012-12-31105,438USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-10-01 to 2013-12-3159,030USD92
2013-07-01 to 2013-12-31-4,324,968USD184
2005-05-12 to 2013-12-31-7,226,686USD3156
2012-10-01 to 2012-12-3135,219USD92
2012-07-01 to 2012-12-31-175,096USD184

Inspect the source

Entity
NANOVIRICIDES, INC. / CIK 0001379006
Captured
2026-09-20T07:58:03.748Z
SEC response SHA-256
5d15adcbc42d7ac8bfebbf748da8ae31563dd5d02e790dc3e1b9bde076c805d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001379006.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))